about
The structure of siglec-7 in complex with sialosides: leads for rational structure-based inhibitor designLarge-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanismsDiversity of microbial sialic acid metabolismStructural implications of Siglec-5-mediated sialoglycan recognitionDengue Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to HyperpermeabilitySialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharidesGlycosylation influences the lectin activities of the macrophage mannose receptorA study of CD33 (SIGLEC-3) antigen expression and function on activated human T and NK cells: two isoforms of CD33 are generated by alternative splicingGlycan array screening reveals a candidate ligand for Siglec-8Structural and functional heterogeneity in the CD200R family of immunoregulatory molecules and their expression at the feto-maternal interfaceSialic acid binding domains of CD22 are required for negative regulation of B cell receptor signalingAdvancement of Sialyltransferase Inhibitors: Therapeutic Challenges and OpportunitiesLack of CD47 on nonhematopoietic cells induces split macrophage tolerance to CD47null cellsSialoadhesin (CD169) expression in CD14+ cells is upregulated early after HIV-1 infection and increases during disease progression.Marked defects in the expression and glycosylation of alpha2-HS glycoprotein/fetuin-A in plasma from neonates with intrauterine growth restriction: proteomics screening and potential clinical implications.Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands.9- O-acetylated sialic acids enhance entry of virulent Leishmania donovani promastigotes into macrophages.Alpha2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling.Epitope mapping and key amino acid identification of anti-CD22 immunotoxin CAT-8015 using hybrid β-lactamase displayA second uniquely human mutation affecting sialic acid biology.The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF-β secretion from monocytes/macrophages through the DAP12-Syk pathway.Glycoscience finally comes of age.Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation.Conservation of structure and mechanism in primary and secondary transporters exemplified by SiaP, a sialic acid binding virulence factor from Haemophilus influenzae.Loss of Siglec expression on T lymphocytes during human evolution.CD33/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in miceIsotype control of B cell signaling.Involvement of sialoadhesin in entry of porcine reproductive and respiratory syndrome virus into porcine alveolar macrophagesControl of myeloid activity during retinal inflammation.Siglec receptors impact mammalian lifespan by modulating oxidative stress.Attenuation of phagocytosis of xenogeneic cells by manipulating CD47.Germinal center marker GL7 probes activation-dependent repression of N-glycolylneuraminic acid, a sialic acid species involved in the negative modulation of B-cell activation.Tumour-targeted chemotherapy with immunoconjugates of calicheamicin.Cell receptors for influenza a viruses and the innate immune responseTrophoblast invasion.A new self: MHC-class-I-independent natural-killer-cell self-tolerance.Deficits in sialylation impair podocyte maturation.68Ga-DOTA-Siglec-9--a new imaging tool to detect synovitisBone marrow dendritic cell-mediated regulation of TLR and B cell receptor signaling in B cellsSialic acid metabolism and sialyltransferases: natural functions and applications.
P2860
Q24553353-93C51CAE-7F78-480F-BFB8-CBF8EA47B9DEQ24561895-A51BCBA7-3433-4FF4-8677-A2D316B72862Q24594315-0E87B9C3-A57D-4315-8EBA-DDE914026C27Q24646384-DFDCCFF7-553B-4B3C-9C8B-C8823175483DQ26700100-A2BCAE55-F977-45C7-BFBE-66DA5B0E0426Q28247592-8FE5A700-A65B-46F6-BDCD-613B81FAD4B1Q28258609-BB22A110-2E83-4E85-AE95-FDB8AE09DC0DQ28288986-2DC22839-81CF-45D7-83AF-6A71CF5160FCQ28295084-87A51F8C-2CFC-4F2F-9804-5BC6B016FA61Q28591277-F1CA0E5C-1AAE-4CA0-B29D-911DFBADC0D1Q28613809-A50E2FD7-377B-4B87-BA32-311CF6F81986Q30039640-63103F47-B4CF-413E-9522-3A55C16CE92BQ30479893-8F09CE7F-2EA0-4C9C-BE25-4CD7D4BC4F4BQ33276138-AD634751-43C9-47FE-9D33-E3F06E820E68Q33309151-83098FAC-D55F-4326-B097-702576DC0766Q33343091-18A9397A-18E3-4F2D-8D92-30CD359A5DB8Q33392744-B8C9103B-437F-40F3-B100-569446616ECCQ33673746-57593911-106B-4169-81BB-FFB721D08E74Q33772436-748E33D4-BB90-4934-AE2A-57E6AAAA9375Q34090387-812D6FDB-40A1-4676-A0A5-1F523723E12CQ34303768-31B147D7-611C-4D4F-8AEB-7619A485D280Q34360659-258CF734-2D4B-4CEE-AD51-9CAEF8BADCFEQ34403249-65CF3A14-9F47-4AF7-A1A6-848CDEDB0C10Q34526447-A0123832-4F0D-4CBA-91BA-168983A82360Q34650845-A118F3F5-828F-4C72-8239-4F8787CF0FC7Q35019914-4F677661-7137-47C4-AACA-45FCFFE9082FQ35138313-D554409C-8EEF-4E05-B292-61F3250DF597Q35155052-EC6E50DB-9B63-4A14-94DD-EC068D6B821EQ35186801-CACDFDC9-B3D8-45BE-8E35-167B02D0CDC6Q35260565-84E5181F-5E8E-4644-8313-F98EBDED99F9Q35615856-0587275B-93BF-4027-9EA6-BC5C958A57BEQ35856788-92A073A1-8366-4F8D-B181-1CB0226AED3DQ35873771-A8F58FF3-DA17-4CF2-9D91-17DF1A7092E9Q35904587-144D2550-411D-437C-B878-E8ED2BA4AFEAQ35980078-2A572323-FA08-4419-A5A7-34DB771F21F9Q36102621-8661E12B-62C1-4898-9D26-5BBDDE3A18CFQ36109169-F4E76566-42DB-485E-8354-928600A89374Q36246891-B2972D95-29CC-49B5-9646-99706BF07F87Q36392561-4D7FE5E8-A91E-43D0-AE23-6EC22D8AC058Q36501918-82A5189F-57F8-4962-A8F1-04C94B0DB21E
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Siglecs, sialic acids and innate immunity.
@ast
Siglecs, sialic acids and innate immunity.
@en
Siglecs, sialic acids and innate immunity.
@nl
type
label
Siglecs, sialic acids and innate immunity.
@ast
Siglecs, sialic acids and innate immunity.
@en
Siglecs, sialic acids and innate immunity.
@nl
prefLabel
Siglecs, sialic acids and innate immunity.
@ast
Siglecs, sialic acids and innate immunity.
@en
Siglecs, sialic acids and innate immunity.
@nl
P1433
P1476
Siglecs, sialic acids and innate immunity.
@en
P2093
P304
P356
10.1016/S1471-4906(01)01930-5
P577
2001-06-01T00:00:00Z